| FDA pulls Avandia (rosiglitazone) from retail pharmacy shelves. |
|
| FDA: FDA has modified the REMS for Avandamet and Avandaryl because previously, the REMS consisted of only a Medication Guide. The REMS, which now includes a restricted access and distribution program, applies to all three rosiglitazone products. |